20298 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin Lactones
Treatment of chronic obstructive pulmonary disease (COPD)
#902Compositions comprising rutin useful for the treatment of tumors resistant to chemotherapy
#903Treatment of CYR61- and VEGF-mediated conditions
#904MITOCHONDRIA AND HUMAN IMMUNODEFIENCY VIRUS TYPE 1 TRANSMISSION
#905Use of wilforlide A for overcoming chemotherapy resistance
#906NASAL FORMULATIONS OF BENZODIAZEPINE
#907Antibody which specifically reacts with human integrin A6B4
#908METHODS FOR TREATMENT OF MICROCEPHALY ASSOCIATED AUTISM DISORDERS
#909ANDROGRAPHIS PANICULATA EXTRACT
#910Composition for treating immune diseases containing daurinol compound as active ingredient
#911Ketone bodies and ketone body esters as blood lipid lowering agents
#912COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES
#913Treatment of pemphigus
#914Immunosuppressive compounds and therapeutics
#915Application of andrographolide in the preparation of a pharmaceutical for treatment of inflammatory bowel disease, andrographolide enteric targeting micropellet, and method for preparation thereof
#916METHOD FOR PRODUCING TRIPTOLIDE
#917Compositions and methods for treating cancer
#918MATERIALS FOR POSITIVE CATHEPSIN B MODULATION AND METHODS OF USE FOR TREATING MILD COGNITIVE IMPAIRMENT (MCI), EARLY DEMENTIA, A-SYNUCLEINOPATHY, TRAUMATIC BRAIN INJURY, CARDIOMYOPATHY, EYE DISEASE AND SKIN DAMAGE
#919Use of flibanserin in the treatment of obesity
#920METHOD OF TREATMENT OF PREMALIGNANT AND MALIGNANT SKIN LESIONS WITH CYTOTOXIC AGENTS
#921Therapeutic Methods and Compositions
#922Animal training using cognitive enhancement
#923Method of treating cancer that overexpresses TopBP1
#924Small molecular inhibitors of RAD51 recombinase and methods thereof
#925Oral pharmaceutical composition containing combination of PPARa and a HMG-CoA reductase inhibitor
#926Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception
#927Method for preventing or treating neurodegenerative diseases
#928METHOD FOR SEPARATING THERAPEUTIC AGENT FOR CHRONIC MYELOGENOUS LEUKEMIA FROM BARK OF LIRIODENDRON TULIPIFERA L.
#929PHARMACEUTICAL COMPOSITION CONTAINING LIRIODENDRON TULIPIFERA L. EXTRACT FOR TREATING CHRONIC MYELOGENOUS LEUKEMIA
#930Pharmaceutical preparations
#931Synthesis of resorcylic acid lactones useful as therapeutic agents
#932KILLING ANTIBIOTIC-RESISTANT BACTERIA WITH A FORMULATION THAT IS SAFE FOR ORAL ADMINISTRATION
#933COMBINED DRUG ADMINISTRATION OF DALCETRAPIB AND ORLISTAT
#934METHODS OF STIMULATING CELLULAR GROWTH, SYNAPTIC REMODELING AND CONSOLIDATION OF LONG-TERM MEMORY
#935Neprilysin inhibitors
#936Methods and compositions for preventing and treating electrophile-mediated toxicities
#937Reagents and methods for cancer treatment and prevention
#938Methods And Compositions For Preventing Or Treating Obesity
#939SERCA INHIBITOR AND CALMODULIN ANTAGONIST COMBINATION
#940A Composition for Lightening Skin and Hair
#941Compounds, substrates and methods related to histone deacetylases
#942CDC7 kinase inhibitors and uses thereof
#943METHOD FOR IMPROVING THE OXYGEN-RELEASING ABILITY OF HEMOGLOBIN TO ORGANS AND PERIPHERAL TISSUES IN HUMAN BODIES AND A MEDICATION THEREOF
#944Method of making a paper and paperboard and the paper and paperboard thereof
#945Stable veterinary combination formulations of macrocyclic lactones and imidazothiazoles
#946Methods for Alzheimer'S disease treatment and cognitive enhancement
#947Use of a macrocyclic lactone for treating a complication from a papilloma virus infection
#948METHODS OF TREATMENT USING AN INTERFERON GAMMA INHIBITOR
#949Anticancer miliusane derivatives
#950Angiopoietin-based interventions for treating cerebral malaria
#951Methods for modulating chemotherapeutic cytotoxicity
#952Compounds and methods for inducing chondrogenesis
#953Tannin inhibitors of HIV
#954INTRAVENOUS FORMULATIONS OF TRIPTOLIDE COMPOUNDS AS IMMUNOMODULATORS AND ANTICANCER AGENTS
#955Oligo-benzamide compounds and their use in treating cancers
#956Methods of producing cancer compounds
#957Diterpenoid membranolide compounds having anti-leishmania activity and uses thereof
#958PHARMACEUTICAL FORMULATION COMPRISING LIPASE INHIBITOR HAVING INCREASED DISSOLUTION RATE AND REDUCED SIDE EFFECTS, AND METHOD FOR PREPARING SAME
#959Treatment of lymphangioleiomyomatosis
#960Compositions and methods for treating cancer
#961PHARMACEUTICAL COMPOSITIONS FOR INHIBITING ANGIOGENESIS
#962Method for treating and/or delaying the degeneration of Purkinje cells
#963Biologically active macrolides, compositions, and uses thereof
#964Derivative of homoserine lactone, and preparation method and use thereof
#965Cancer therapy using miRNAs
#966Edible energy composition
#967Gem-difluorinated C-glycoside compounds as anti-cancer agents
#968Method for treating skin cancer using radiation therapy
#969Method for treating pancreatic cancer
#970Treatment of Alzheimer's and Cognitive Impairment With Andrographolides
#971Method of treating or reducing the severity of dermatological conditions
#972TREATMENT OF LATENT HIV INFECTION
#973Stable pharmaceutical composition
#974Small molecule antagonists of bacterial quorum-sensing receptors
#975Compositions for delivery of oral comfort sensations
#976Calcium flux agonists and methods thereof
#977Methods and compositions for treatment of lipid storage disorders
#978Combination therapeutics and methods for the treatment of neurodegenerative and other diseases
#979Ingenol-3-acylates III and ingenol-3-carbamates
#980Combination of local and systemic immunomodulative therapies for melanoma and liver cancer
#981COMPOSITIONS AND METHODS OF USING SAME
#982Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
#983Transdermal parasiticidal formulations
#984Liposomes for in-vivo delivery
#985Hyaluronic Acid Decomposition-Promoting Factor and Inhibitor Thereof
#986SMALL MOLECULES AS ANTI-HIV AGENTS THAT DISRUPT VIF SELF-ASSOCIATION AND METHODS OF USE THEREOF
#987Coumarin compounds as receptor modulators with therapeutic utility
#988INJECTABLE CANCER COMPOSITIONS
#989Means and method for treating solid tumors
#990Cognitive function
#991Drug delivery system and method for the treatment of neuro-degenerative disease
#992Methods and Compositions For Treating Hepatocellular Carcinoma
#993Extracts of cynara scolymus, coffea ssp. and olea europaea for the treatment of metabolic syndrome
#994THERAPY FOR CONSTIPATION
#995Methods of treating skin conditions using cyclolignan compounds
#996METHODS OF REACTIVATING A LATENT HUMAN IMMUNODEFICIENCY VIRUS
#997Compositions for oral administration to animals, production methods thereof and uses of same
#998Methods of treating skin conditions using cyclolignan compounds
#999Spirocyclic isoxazoline parasiticidal combinations
#1000FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES
#1001Devices and methods for facilitating and controlling use of a medication
#1002Compositions and methods for enhancing virus efficacy
#1003Pharmaceutical compositions of anisomelic acid and the use thereof
#1004Anti-cancer agent
#1005Prion protein ligands as therapeutic agents for neurodegenerative disorders
#1006Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies
#1007Antiparisitic dihydroazole compounds and compositions comprising same
#1008MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER
#1009Methods and Compositions for Modulating Beta Cell Proliferation
#1010Treprostinil derivative compounds and methods of using same
#1011Compositions That Include Anthocyanidins and Methods of Use
#1012Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
#1013COMBINATION COMPRISING PARTHENOLIDE FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
#1014fruit extract
#1015COMBINATION OF SYROSINGOPINE AND MITOCHONDRIAL INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNOSUPPRESSION
#1016Combination therapy for the treatment of cancer and immunosuppression
#1017ANDROGRAPHOLIDE ANALOGS AND THEIR USE FOR MEDICATION
#1018Artemisinin with berberine compositions and methods of making
#1019Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammation
#1020Monascuspurpurones, preparation and uses thereof
#1021Methods and compositions for the inhibition of Pin1
#1022NOVEL PRO- AND CODRUG DERIVATIVES FOR NANOPARTICLE DELIVERY OF SELECT ANTICANCER AGENTS FORMED USING RAPIDLY CLEAVABLE PHENOLIC ESTER BRIDGES
#1023Lichesterinic acid and the derivatives of same as pigmentation inhibitors
#1024Line leaf inula flower lactone A and methods for preparing and using the same for treating multiple sclerosis
#1025Line leaf inula flower lactone A and methods for preparing and using the same for treating myocarditis
#1026Transplantation therapies
#1027Anti-aging agent containing arctigenin derivative
#1028Method of Modifying Fertility
#1029NUTRITIONAL ENERGY AND FOCUS SUPPLEMENT
#1030Modulation of bacterial quorum sensing with synthetic ligands
#1031Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
#1032Use of Flibanserin in the Treatment of Obesity
#1033PELTATIN FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISORDERS
#1034THERAPEUTIC NANOPARTICLES WITH HIGH MOLECULAR WEIGHT COPOLYMERS
#1035Angiogenesis inhibitors
#1036Use of 15-benzylidene-14-deoxy-11, 12-dehydroandrographolide derivative in manufacture of medicaments for protecting liver and anti-hepatitis C virus
#1037Compounds from Anisomeles Heyneana
#1038Method for treatment of diarrhea-predominant irritable bowel syndrome
#1039PELTATIN AND METABOLIC DISORDERS
#1040Long acting compositions
#1041Dihydrofuran azetidine derivatives as antiparasitic agents
#1042Compositions and methods for treating cancer
#1043Methods of Treating Serosal Cancer
#1044Methods and compositions for treating leukemia
#1045GABAA RECEPTOR ANTAGONISTS AFFECTING GANGLION CELL FUNCTION AND VISUAL ACUITY
#1046Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonists
#1047Diagnosis and treatment for respiratory tract diseases
#1048Method for extracting treatment ingredients for gastrointestinal diseases from bark of liriodendron tulipifera
#1049Pharmaceutical Composition Containing as Active Ingredient Extract From Bark of Liriodendron Tulipifera
#1050Sorbent comprising on its surface a cationic or protonizable aliphatic residue for the purification of organic molecules
#1051Method of treating overactive bladder, not due to cancer, by administering at least one jasmonate
#1052Methods and systems for modulating hormones and related methods, agents and compositions
#1053Monascuspurpurones, preparation process thereof, and uses of the monascuspurpurones
#1054Treatment of sickle cell disease
#1055Method for chemical synthesis of antrocin and use thereof for suppressing non-small cell lung cancer
#1056Ellagitannins rich extracts composition in sexual wellness
#1057METHODS AND PRODUCTS TO DIAGNOSE AND TREAT HEATINESS
#1058Compositions for oral administration to animals, processes for obtaining the same and the uses thereof
#1059Methods and compositions for enhancing the uptake of therapeutic agents by target cells
#1060Oligo-benzamide compounds and their use in treating cancers
#1061Use of strigolactones and strigolactone analogs for treating proliferative conditions
#1062Long-acting injectable moxidectin formulations and novel moxidectin crystal forms
#1063Mycophenolic acid analogues as anti-tumor chemosensitizing agents
#1064Ellagitannins rich extracts composition
#1065PKC activators and combinations thereof
#1066Antiparisitic dihydroazole compounds and compositions comprising same
#1067METHODS FOR TREATING OR PREVENTING FIBROSIS IN SUBJECTS AFFLICTED WITH SCLERODERMA
#1068Treatment of diseases related to alpha subunits of sodium channels, voltage-gated (SCNxA) with small molecules
#1069Use of flaxseed and flaxseed derivatives for treatment of neurological disorders and viral diseases
#1070Primycin and components thereof for use in the treatment or prevention of infections caused by specific pathogens
#1071Pharmacological treatment of cognitive impairment
#1072Temperature sensitive liposome including cationic lipid and use thereof
#1073Derivative of butylphthalide and preparation method and use thereof
#1074Small molecule antagonists of bacterial quorum-sensing receptors
#1075Compounds and methods for inducing chondrogenesis
#1076Composition and method for preventing, reducing, alleviating or treating idiopathic vomiting
#1077PHARMACO-CELLULAR THERAPEUTIC METHOD FOR THE TREATMENT OF MUSCULAR DYSTROPHIES
#1078Tumor necrosis factor inhibitors
#1079Aminoglycoside and azole compositions and methods
#1080Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones
#1081Use of deoxyelephantopin (DET) and analogues thereof for reducing side effects of an anti-cancer agent
#1082INHIBITING GS-FDH TO MODULATE NO BIOACTIVITY
#1083extracts for the treatment of dyslipidaemia
#1084Sigma receptors ligands with anti-apoptotic and/or pro-apoptotic properties, over cellular mechanisms, exhibiting prototypical cytoprotective and also anti-cancer activity
#1085Methods to detect, treat and prevent acute cellular rejection in kidney allografts
#1086Cytotoxin compounds and methods of isolation
#1087Anthelmintic Formulations and Treatments
#1088HEALTH SUPPLEMENT
#1089USES OF C15-SUBSTITUTED ANDROGRAPHOLIDE DERIVATIVES IN THE PREPARATION OF ANTI-HEPATITIS B VIRUS MEDICAMENT
#1090Composition and use of hydrogenated alkyl ketene dimers
#1091Pharmaceutical compositions and method for inhibiting angiogenesis
#1092PRESERVATION OF THE NEUROMUSCULAR JUNCTION (NMJ) AFTER TRAUMATIC NERVE INJURY
#1093Use of an anti-CD200 antibody for prolonging the survival of allografts
#1094COMPOSITIONS FOR AMELIORATING SYSTEMIC INFLAMMATION AND METHODS FOR MAKING AND USING THEM
#1095Migraine Treatment
#1096METHODS AND COMPOSITIONS FOR ENHANCING THE UPTAKE OF THERAPEUTIC AGENTS BY TARGET CELLS
#1097COMPOSITION AND METHOD FOR INFLUENCING ENERGY METABOLISM AND TREATING METABOLIC AND OTHER DISORDERS
#1098Therapy for Constipation
#1099Compositions and methods for treating cancer
#1100Compositions and methods of inhibiting N-acylethanolamine-hydrolyzing acid amidase
#1101SSH-2 (slingshot-2) inhibitors and methods for making and using them
#1102PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION
#1103Composition containing arylnaphthalene lignan derivative for preventing and/or treating dementia
#1104INFLAMMATORY EYE DISEASE
#1105Small molecular inhibitors of RAD51 recombinase and methods thereof
#1106Identification of compounds that disperse TDP-43 inclusions
#1107Macrocyclic lactones and use thereof
#1108Covalent inhibition of bacterial quorum sensing
#1109Pharmaceutical composition and methods for peptide treatment
#1110Compositions and methods for treating multi-drug resistant malaria
#1111Andrographis Paniculata Compositions and Methods for Treatment of Addictions
#1112GRANZYME B INHIBITOR COMPOSITIONS, METHODS AND USES FOR PROMOTING WOUND HEALING
#1113Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
#1114INHIBITORS OF THE ACTIVITY OF COMPLEX III OF THE MITOCHONDRIAL ELECTRON TRANSPORT CHAIN AND USE THEREOF FOR TREATING DISEASES
#1115Method of using antimycin A to downregulate Wnt/b-catenin pathway to treat gefitinib resistant cancer
#1116Method for inhibiting autophagy of motor neurons
#1117Burdock fruit extract containing arctigenin and method for producing same
#1118Small molecule antagonists of bacterial quorum-sensing receptors
#1119Microbicidal and antiparasitic compositions
#1120Methods of treating muscular wasting diseases using NF-KB activation inhibitors
#1121ANDROGRAPHIS PANICULATA EXTRACT
#1122COX-2 INHIBITORS AND RELATED COMPOUNDS, AND SYSTEMS AND METHODS FOR DELIVERY THEREOF
#1123Therapeutic peptides
#1124TREATMENTS FOR CELLULAR PROLIFERATIVE DISORDERS AND IDENTIFICATION THEREOF
#1125COMPOSITIONS AND METHODS FOR POTENTIATING SONOTHROMBOLYSIS
#1126Picropodophyllin Monohydrate or Polymorph A in Cancer Therapy
#1127Treatment of cognitive disorders associated with abnormal dendritic spines using PKC activators
#1128GLP-1 potentiators from hedychium coronarium and their applications
#1129TREATMENT OF PEMPHIGUS
#1130C-GLUCOSIDIC ELLAGITANNIN COMPOUNDS FOR USE FOR ALTERING THE SUPRAMOLECULAR ARRANGEMENT OF ACTIN AND FOR THE TREATMENT OF OSTEOPOROSIS, CANCER, BACTERIAL INFECTION AND VIRAL INFECTION
#1131Methods and compositions for preventing and treating auditory dysfunctions
#1132Picropodophyllin polymorph C and its use in cancer therapy
#1133Use of albiflorin and metabolites thereof
#1134Combination and composition for treating obesity
#1135Tricyclic lactones for treatment of cancer
#1136Anti-angiogenic composition containing macrolactin A and a derivative thereof as active ingredients
#1137Multikinase inhibitors for use in the treatment of cancer
#1138Chemosensory Receptor Ligand-Based Therapies
#1139Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections
#1140Skin whitening agent
#1141Methods for Alzheimer's disease treatment and cognitive enhancement
#1142Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA)
#1143Combination of syrosingopine and mitochondrial inhibitors for the treatment of cancer and immunosuppression
#1144Pharmaceutical compositions comprising 8-substituted dibenzylbutyrolactone lignans
#1145Functional food preparation and use thereof
#1146PHARMACEUTICAL COMPOSITIONS OF IMMUNOSUPPRESSANTS
#1147Compositions and method for improving endothelial function and cardiovascular health
#1148Pharmaceutical composition, methods for treating and uses thereof
#1149Uses of 15-benzylidene-14-deoxy-11,12-didehydroandrographolide derivatives in the preparation of antineoplastic drugs
#1150NEURONAL CIRCUIT-DEPENDENT NEUROPROTECTION BY INTERACTION BETWEEN NICOTINIC RECEPTORS
#1151Lactam derivatives useful as orexin receptor antagonists
#1152SPOT-ON PESTICIDE COMPOSITION CONTAINING A PYRETHROID AND MACROCYCLIC LACTONE
#1153METHOD AND COMPOSITION FOR TREATING ALZHEIMER'S DISEASE AND DEMENTIAS OF VASCULAR ORIGIN
#1154AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES
#1155Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
#1156METHODS FOR TREATING STRESS INDUCED EMOTIONAL DISORDERS
#1157COMBINATIONS COMPRISING A PROTEIN KINASE INHIBITOR BEING A PYRIMIDYLAMINOBENZAMIDE COMPOUND AND A HSP90 INHIBITOR SUCH AS 17-11G
#1158Applications Of Arctigenin In Formulating Drugs For Preventing Or Treating Diseases Related To Red Blood Cell Reduction
#1159Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels
#1160Method for manufacturing composition for lowering blood lipid and elevating high-density lipoprotein
#1161Method for manufacturing composition for lowering blood lipid and elevating high-density lipoprotein
#1162Method of treating otitis externa using macrocyclic lactone compound
#1163Method of treating hemorrhoids using macrocyclic lactone compound
#1164Method of treating herpes virus infection using macrocyclic lactone compound
#1165Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors
#1166THERAPEUTIC EFFECTS OF BRYOSTATINS, BRYOLOGS, AND OTHER RELATED SUBSTANCES ON ISCHEMIA/STROKE-INDUCED MEMORY IMPAIRMENT AND BRAIN INJURY
#1167Treatment of depressive disorders
#1168Drug delivery system and method for the treatment of neuro-degenerative disease
#1169Improving efficacy of cancer therapy
#1170Long-acting injectable moxidectin formulations and novel moxidectin crystal forms
#1171Methods of treatment using combination therapy
#11727-HYRDROXYFRULLANOLIDE ITS ANALOGS FOR PREVENTION CONTROL AND TREATMENT OF METABOLIC DISORDERS
#1173Anti-cancer active substance from , method for preparing the same and use thereof
#1174Xanthanodien for the treatment of cancer
#1175Anti-human urothelial carcinoma of supercritical carbon dioxide extract of , and the preparation process and uses
#1176Micheliolide derivatives, medicinal composition, producing method and usage thereof
#1177ANTI-ANGIOGENIC COMPOSITION CONTAINING MACROLACTIN A AND A DERIVATIVE THEREOF AS ACTIVE INGREDIENTS
#1178Combination of Selected Analgesics and Cox-II Inhibitors
#1179Neprilysin inhibitors
#1180Artemisinin with berberine compositions and methods of making
#1181Mitochondria and human immunodefiency virus type 1
#1182Hyaluronic acid decomposition-promoting factor and inhibitor thereof
#1183Compositions and methods for inhibiting human host factors required for influenza virus replication
#1184THERAPEUTIC COMPOSITIONS
#1185LIPASE INHIBITING COMPOSITION
#1186Use of flibanserin in the treatment of obesity
#1187Tumor necrosis factor inhibitors
#1188PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPalpha SECRETION AND IMROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS
#1189Treatment of viral infections by modulation of host cell metabolic pathways
#1190Treatment methods utilizing stem cell mobilizers and immunosuppressive agents
#1191USE OF CIS-EPOXYEICOSATRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO TREAT CONDITIONS MEDIATED BY PBR, CB2, and NK2 RECEPTORS
#1192DELIVERY SYSTEM FOR SPECIFICALLY TARGETING CANCER CELLS AND METHOD OF USE THEREOF
#11934′-demethylepipodophyllotoxin derivative, preparation method and use thereof
#1194Film delivery system for tetrahydrolipstatin
#1195CDC7 kinase inhibitors and uses thereof
#1196USE OF TRICYCLIC SESQUITERPENE LACTONES IN THE TREATMENT OF OBESITY AND RELATED DISEASES AND NON-THERAPEUTIC TREATABLE CONDITIONS
#1197extract
#1198Compounds and compositions for treating infection
#1199Composition for Lowering Blood Lipid and Elevating High-density Lipoprotein and Method for Manufacturing the Same
#1200Pharmaceutical Composition of Mycophenolate Mofetil and Process for Preparing Thereof